Preciva has developed a portable, wireless electronic cervical tissue diagnosis system. The invention consists of a bioprobe with a disposable tip and a set of electrodes that stimulate the cervix with low voltage electrical signals. The bioprobe communicates wirelessly with a standard desktop or laptop to facilitate cervical tissue analysis. This makes the system portable and inexpensive and will directly produce electronic data records. The Preciva system has a number of advantages over the typical Pap test for diagnosing cervical cancer. The wireless use of electrical measurements can give the examiner immediate feeback and help ensure that the examiner samples the entire cervix, including the cervical canal. The system also avoids abrasive tissue collection while improving accuracy by sampling the entire cervix. Finally, Preciva’s system provides immediate test results without a need for laboratory infrastructure, reducing the cost of cervical cancer screening and allowing clinics to see and treat disease in a single patient visit. This system holds potential for increasing cervical cancer screening in low-income areas, especially given its portable nature and its lack of dependence on laboratory capabilities.